Evidence That Orexigenic Effects of Melanocortin 4 Receptor Antagonist HS014 Are Mediated by Neuropeptide Y

By Kask A.   Rago L.   Korrovits P.   Wikberg J.E.S.   Schioth H.B.  

Biochemical and Biophysical Research Communications, Vol. 248, Iss. 2, 1998-07 ,pp. : 245-249

Elsevier

Access to resources Recommend Favorite

The Melanocortin 4 Receptor Mediates Leptin Stimulation of Luteinizing Hormone and Prolactin Surges in Steroid-Primed Ovariectomized Rats

By Watanobe H.   Schiöth H.B.   Wikberg J.E.S.   Suda T.  

Biochemical and Biophysical Research Communications, Vol. 257, Iss. 3, 1999-04 ,pp. : 860-864

Elsevier

Access to resources Recommend Favorite

Production of recombinant CART peptides in Escherichia coli with agonist and antagonist effects on food intake in rats

By Couceyro P.R.   Fritz T.  

Protein Expression and Purification, Vol. 32, Iss. 2, 2003-12 ,pp. : 185-193

Elsevier

Access to resources Recommend Favorite

Synthesis of novel melanocortin 4 receptor agonists and antagonists containing a succinamide core

By Xi N.   Hale C.   Kelly M.G.   Norman M.H.   Stec M.   Xu S.   Baumgartner J.W.   Fotsch C.  

Bioorganic and Medicinal Chemistry Letters, Vol. 14, Iss. 2, 2004-01 ,pp. : 377-381

Elsevier

Access to resources Recommend Favorite

Cysteine Residues Are Involved in Structure and Function of Melanocortin 1 Receptor: Substitution of a Cysteine Residue in Transmembrane Segment Two Converts an Agonist to Antagonist

By Frändberg P-A.   Doufexis M.   Kapas S.   Chhajlani V.  

Biochemical and Biophysical Research Communications, Vol. 281, Iss. 4, 2001-03 ,pp. : 851-857

Elsevier

Access to resources Recommend Favorite